DiscoverAt the Intersection of Science and LawRevolutionizing Clinical Trials: A discussion on diversity and patient-centric approaches
Revolutionizing Clinical Trials: A discussion on diversity and patient-centric approaches

Revolutionizing Clinical Trials: A discussion on diversity and patient-centric approaches

Update: 2024-11-15
Share

Description

In this episode, Quest Diagnostics’ Adam Donat is joined by DLA Piper’s Kirsten Axelsen, Rachel Portman, and Jae Kim to discuss the increasing complexity and cost of clinical trials, new FDA guidance, innovative trial designs and tools, and what’s expected in the new year.

See omnystudio.com/listener for privacy information.

Comments 
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Revolutionizing Clinical Trials: A discussion on diversity and patient-centric approaches

Revolutionizing Clinical Trials: A discussion on diversity and patient-centric approaches

DLA Piper